The trademark application APRESYN was filed by TEVA Pharmaceuticals Europe B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on July 1, 2014, and it was registered by office on October 8, 2014 without any oppositions.
The application was filed in English (French was selected as the second language).
The renewal of the trademark was recorded by the office on May 6, 2024.
Change of name and address of the trademark registration was recorded on April 20, 2015. Appointment and Replacement of representative of the trademark registration was recorded on July 30, 2020. Change of name and professional address of the trademark registration was recorded on September 1, 2020.